Correspondence 0001104659-24-109504 from ROCKWELL MEDICAL, INC. (RMTI) (CIK 0001041024) (RMTI)
ROCKWELL MEDICAL, INC. (RMTI) (CIK 0001041024)
Date: Oct. 17, 2024 · CIK: 0001041024 · Accession: 0001104659-24-109504
AI Filing Summary & Sentiment
File numbers found in text: 333-282538
Letter
VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences Washington, D.C. 20549-3561 Re: Rockwell Medical, Inc. Registration Statement on Form S-3 File No. 333-282538
Dear Mr. Gorsky:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Rockwell Medical, Inc. (the “Company”), hereby requests acceleration of the effective date of the above-referenced Registration Statement to 4:00 p.m., Eastern Time, on October 21, 2024, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Gibson, Dunn & Crutcher LLP, requests by telephone that such Registration Statement be declared effective. In making this acceleration request, the Company acknowledges that it is aware of its obligations under the Act. This acceleration request supersedes our prior acceleration request with respect to the above-referenced Registration Statement filed with the Commission on October 17, 2024.
Please contact Ryan Murr of Gibson, Dunn & Crutcher LLP by telephone at (415) 393-8373 or via email at RMurr@gibsondunn.com as soon as the Registration Statement has been declared effective, or if you have any other questions or concerns regarding this matter. We also respectfully request that a copy of the written order from the Commission verifying the effective time of such Registration Statement be sent to Mr. Murr via email at RMurr@gibsondunn.com.
Sincerely,
/s/ Mark Strobeck
Show Raw Text
CORRESP
1
filename1.htm
ROCKWELL MEDICAL, INC.
30142 S. Wixom Road
Wixom, MI 48393
October 17, 2024
VIA EDGAR
Joshua Gorsky
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, NE
Washington, D.C. 20549-3561
Re: Rockwell Medical, Inc.
Registration
Statement on Form S-3
File No. 333-282538
Dear Mr. Gorsky:
Pursuant to Rule 461
under the Securities Act of 1933, as amended (the “Act”), Rockwell Medical, Inc. (the “Company”), hereby
requests acceleration of the effective date of the above-referenced Registration Statement to 4:00 p.m., Eastern Time, on October 21,
2024, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Gibson, Dunn & Crutcher
LLP, requests by telephone that such Registration Statement be declared effective. In making this acceleration request, the Company acknowledges
that it is aware of its obligations under the Act. This acceleration request supersedes our prior acceleration request with respect to
the above-referenced Registration Statement filed with the Commission on October 17, 2024.
Please contact Ryan Murr
of Gibson, Dunn & Crutcher LLP by telephone at (415) 393-8373 or via email at RMurr@gibsondunn.com as soon as the Registration
Statement has been declared effective, or if you have any other questions or concerns regarding this matter. We also respectfully request
that a copy of the written order from the Commission verifying the effective time of such Registration Statement be sent to Mr. Murr
via email at RMurr@gibsondunn.com.
Sincerely,
/s/ Mark Strobeck
Name: Mark Strobeck, Ph.D.
Title: President and Chief Executive
Officer
cc: Ryan Murr
Gibson, Dunn &
Crutcher LLP